Latest Investor Confidence News

St Barbara Limited updates its FY25 gold production guidance amid temporary mining delays caused by heavy rainfall at Simberi, while maintaining steady cost expectations and financial resilience.

DigiCo Infrastructure REIT has announced a FY25 distribution of 10.90 cents per security, aligning with its initial guidance and reflecting steady income returns for investors.

Linius Technologies secures $3.3 million through share placement and convertible notes, appointing former AFL CEO Andrew Demetriou to its board as it accelerates commercial momentum under new leadership.

Astron Corporation is set to redomicile from Hong Kong to Australia, establishing a new Australian parent company and simplifying shareholder engagement. This move aims to align governance with local standards and boost investor confidence.

Western Gold Resources Limited has had its trading suspension lifted following an announcement about ongoing negotiations or entry into a material agreement, signaling renewed market activity.

Western Gold Resources has confirmed a binding toll milling agreement with Wiluna Mining Corporation, explaining recent unusual trading activity in its shares.

Boab Metals has raised A$6 million through a placement to advance its Sorby Hills lead-silver-zinc project, aiming to accelerate pre-development and exploration activities ahead of a final investment decision.

4DS Memory reports initial testing of its latest 20nm memory cell arrays fell short of expectations, potentially delaying its Interface Switching ReRAM technology development. Further analysis and testing are underway to pinpoint the issues.

Solstice Minerals secures a $2.13 million strategic placement from Paradice Investment Management, making Paradice its largest shareholder and fueling exploration at key Western Australian projects.

Toubani Resources has initiated a 5,000-metre diamond drilling campaign at its Kobada Gold Project in Mali, targeting deeper mineralisation to expand its 2.2 million ounce resource and extend mine life.

Bubs Australia has submitted critical clinical trial data to the US FDA, marking a pivotal step toward permanent approval for its infant formulas in the US market.

WCM Global Growth Limited has renewed its on-market share buy-back program for 12 months, signaling ongoing confidence in its capital management strategy amid evolving market conditions.